Search details
1.
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome.
Blood
; 137(23): 3251-3258, 2021 06 10.
Article
in English
| MEDLINE | ID: mdl-33513604
2.
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
Acta Oncol
; 62(7): 744-752, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37039661
3.
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
Int J Cancer
; 148(1): 150-160, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32638373
4.
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
J Allergy Clin Immunol
; 146(2): 356-366.e4, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32437738
5.
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions.
J Allergy Clin Immunol
; 146(2): 300-306, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32561389
6.
Interim thymus and activation regulated chemokine versus interim 18 F-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation.
Br J Haematol
; 190(1): 40-44, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32106342
7.
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial.
Br J Haematol
; 190(3): 385-393, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32150297
8.
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.
Allergy
; 75(8): 1927-1938, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32108361
9.
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.
Br J Haematol
; 184(4): 616-624, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30095158
10.
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
N Engl J Med
; 374(26): 2530-41, 2016 Jun 30.
Article
in English
| MEDLINE | ID: mdl-27355533
11.
Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care.
Crit Care Med
; 47(2): e120-e128, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30335623
12.
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Health Qual Life Outcomes
; 17(1): 115, 2019 Jul 02.
Article
in English
| MEDLINE | ID: mdl-31266501
13.
Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units.
Br J Haematol
; 181(1): 68-76, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29468848
14.
Relapse in stage I(E) diffuse large B-cell lymphoma.
Hematol Oncol
; 36(2): 416-421, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29083044
15.
MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.
Histopathology
; 71(6): 960-971, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28730642
16.
Management around invasive procedures in mastocytosis: An update.
Ann Allergy Asthma Immunol
; 119(4): 304-309, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28866309
17.
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.
J Allergy Clin Immunol
; 137(1): 35-45, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26476479
18.
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.
Haematologica
; 101(10): 1133-1143, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27694501
19.
Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?
J Pathol
; 236(3): 302-14, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25722108
20.
Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.
Br J Haematol
; 165(4): 489-96, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24754632